Colonization by ESKAPES and clinical characteristics of critically ill patients
Abstract
Objective: To identify colonization by ESKAPES and clinical characteristics of patients admitted in Adult Intensive Care Unit of a mixed hospital in Paraná.
Method: Field research, descriptive, documentary and experimental quantitative approach, developed in adult Intensive Care Unit of a mixed hospital in Southwest Paraná, Brazil. The study population consisted of patients with admission from 48 hours in the Intensive Care Unit, from April to August 2018 and April to August 2019. The sample has 102 individuals. For the collection of clinical data, a checklist was used and for microbiological analysis the sample was collected from nasal and oral cavities and tracheal secretion. The analysis of clinical data occurred through the Statistical Package for the Social Sciences software. Descriptive frequency and chi-square test, considering significant p <0,05.
Results: A total of 102 patients admitted to the Intensive Care Unit during the period studied were evaluated. On these ones, 57 (55,8%) were colonized by pathogenic microorganisms. Regarding the colonization of microorganisms, there was predominance of Staphylococcus aureus (61,4%), followed by Klebsiella pneumoniae (40,4%), Pseudomonas aeruginosa (26,3%) and Staphylococcus epidermidis (21,1%). It is noteworthy that Klebsiella pneumoniae and Staphylococcus aureus were present in the three regions evaluated.
Conclusion: The study identified the presence of colonization in critically ill patients studied, being this colonization, mostly, resistant bacteria belonging to the ESKAPE group
Downloads
References
Basso ME, Pulcinelli, RSR, Aquino ARC, Santos KF. Prevalence of bacterial infections in patients admitted to an intensive care unit. Rev bras anal clin. 2016; 48 (4): 383- 388.
Araújo PL, Mendonça AEO, Medeiros RA, Souza Neto VL, Nobre TTX, Costa IKF. Prevalence of health assistance infection in patients hospitalized in intensive therapy unit. Enferm glob. 2018; 17 (52): 291- 303.
Merzoughi L, Barhoumi T, Guizani T, Barhoumi H, Hannachi H, Turki E et al. Nosocomial infections in the Intensive Care Unit: annual incidence rate and clinical aspects. Pan Afr Med J. 2018; 30 (143): 1- 8.
Esposito S, Simone G. Update on the main MDR pathogens: prevalence and treatment options. Infez Med, 2017; 25 (4): 301- 310.
WHO. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. [Internet]. Genebra: WHO; [cited 2017 Feb 27]. Available from: https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/.
WHO. World Health Organization. United Nations meeting on antimicrobial resistance. Bull World Health Organ. 2016; 94 (9): 638- 639.
WHO. World Health Organization. Ten threats to global health in 2019. [Internet]. Genebra: WHO; [cited 2019]. Available from: https://www.who.int/emergencies/ten-threats-to-global-health-in-2019.
Angelis G, Fiori B, Menchinelli G, D’Inzeo T, Liotti FM, Morandotti GA et al. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007- 2015). Eur J Clin Microbiol Infect Dis. 2018; 37 (9): 1627- 1636.
Sun QL, Gu D, Wang Q, Hu Y, Shu L, Hu J et al. Dynamic Colonization of Klebsiella pneumoniae Isolates in Gastrointestinal Tract of Intensive Care Patients. Front Microbiol. 2019; 10: 1- 9.
Estrada-Román A, Mendo-López R, Astocondor L, Zervos M, García C. Colonization by enterococcal strains resistant to vancomycin in patients from a hospital in Lima, Perú. Rev Peru Med Exp Salud Publica. 2017; 34 (4): 666- 671.
Santolin C, Sesma AC, Llansa MA, Pintado S, Masso MG, Mangiaterra SM. Rectal colonisation by multiresistant gram-negative bacilli: relevance of early detection in the course of hospitalization. Acta bioquím clín latinoam. 2017; 51 (4): 675- 680.
Martinez AE, Widmer A, Frei R, Pargger H, Tuchscherer D, Marsch S et al. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome. Infect Control Hosp Epidemiol. 2019; 40 (4): 408- 413.
Costa DM, Johani K, Melo DS, Lopes LKO, Lima LKO, Tipple AFV et al. Biofilm contamination of high-touched surfaces in intensive care units: epidemiology and potential impacts. Lett Appl Microbiol. 2019; 68 (4): 269- 276.
Hespanhol LAB, Ramos SCS, Ribeiro Junior OC, Araújo TS, Martins AB. Infection related to Health Care in an adult Intensive Care Unit. Enferm glob. 2019; 18 (1): 229- 241.
Vieira AM, Parente EA, Oliveira LS, Queiroz AL, Bezerra ISAM, Rocha HAL et al. Characteristics of deaths of hospitalized patients in Intensive Care Unit of a tertiary hospital. J. Health Biol Sci. 2019; 7 (1): 26- 31.
Moura JM, Bertolli ES, Pereira RM, Frutuoso IS, Werneck AL, Contrin LM. Sepsis diagnosis in patients after intensive care unity hospitalization. Arq. Ciênc. Saúde. 2017; 24 (3): 55- 60.
Santos GO, Queiroz RS, Jesus CS, Carneiro JAO, Faria LMA, Fernandes ME et al. Patients admitted to an intensive care unit who do not adopt na antigravity posture have a higher odds of death. Fisioter Pesqui. 2019; 26 (3): 235- 240.
Arcanjo R, Oliveira AC. Factors connected to axillary colonization by resistant organisms of intensive care unit patients. Rev. Aten. Saúde. 2017; 15 (51): 11- 17.
Santos LJ, Silveira FS, Müller FF, Araújo HD, Comerlato JB, Silva MC et al. Functional assessment of impatients in the Intensive Care Unit of the University Hospital of Canoas. Fisioter Pesqui. 2017; 24 (4): 437- 443.
Souza HP, Werneck GL, Medeiros LT, Sabroza PC, Santos JPC. Spatial analysis of causes of death from cardiovascular disease and associated factors in a deployment area of a large development project. Hygeia. 2017; 13 (24): 199- 214.
Barros LLS, Maia CSF, Monteiro MC. Risk factors associated to sepsis severity in patients in the Intensive Care Unit. Cad. Saúde Colet. 2016; 24 (4): 388- 396.
Lima Júnior FA, Vieira SEM, Silva BS, Araújo TD, Reis TGM, Miranda JM et al. Profile of antibiotics prescription in an adult intensive care unit at a surgical reference hospital in the state of Maranhão. REAS/ EJCH. 2019; 34: 1- 7.
Murray PR, Rosenthal KS, Pfaller MA. Microbiologia Médica. 7th ed. Rio de Janeiro: Guanabara Koogan; 2014.
Arias CA, Reyes J, Carvajal LP, Rincon S, Diaz L, Panesso D et al. A prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries. Antimicrob. Agentes chemother. 2017; 61 (10): 1- 12.
Juan CH, Chuang C, Chen CH, Li L, Lin YT. Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia. Antimicrob Resist Infect Control. 2019; 8 (1): 1- 9.
Sanctis G, Ferraris A, Ducatenzeiler L, Benso J, Fernández-Otero L, Angriman F. Risk factors for in-hospital mortality among adult patients infected with colistin-resistant carbapenemase producing Klebsiella pneumoniae: a retrospective cohort study. Rev. chil. Infecto. 2018; 35 (3): 239- 45.
Merjildo DF, Apac CG, Piérola JZ, Bullon LG. Antimicrobial susceptibility among endotracheal isolates in na intensive care unit in Lima, 2016. Rev Med Hered. 2017; 28: 236- 241.
Gómez-González JF, Sánchez-Duque JA. Microbiologic profile and antibiotic resistance at na intensive care unit in Pereira, Colombia, 2015. MÉD. UIS. 2018; 31 (2): 9- 15.
O’neill J. Tackling drug-resistant infections globally: final report and recommendations. Rev Antimicrob Resist. 2016.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
